Adhesive substance at nerve synapses is importantin memory and learning, research shows

PASADENA—A sticky molecule found at the junctions of brain cells may be a crucial chemical ingredient in learning and memory, neuroscientists have discovered.

In the current issue of the journal Neuron, Erin Schuman and her students at the California Institute of Technology report that a calcium-dependent family of molecules known as cadherins plays a significant role in chemically joining the synapses (the junctions of nerves). Neuroscientists believe that the environment of the synapses is where memories are stored.

"These cadherins may form a sort of zipper-like structure at the junction of the presynaptic cell and the postsynaptic cell," says Schuman, who is a Howard Hughes Medical Institute investigator and assistant professor of biology at Caltech

"We show in this study that these molecules participate in making the synapses bigger and stronger, a process called 'long-term potentiation' that may be involved in memory storage."

According to Schuman's graduate student Lixin Tang, who is coauthor of the paper, the new research involves turning off the cadherins to see what happens to long-term potentiation when the synapses have to do without them.

"It has been known for some time that cadherins are important during early development," says Tang. "But they are also expressed well into adulthood. So we were interested in seeing what would happen when cadherin was disrupted in the adult brain."

The researchers shut off the cadherins in the hippocampuses of adult mice and rats with various antibodies targeting various adhesion sites, as well as with inhibitory peptides. The results showed that long-term potentiation was significantly reduced when the cadherins were temporarily inactivated at synapse junctions.

However, the overall signal transmission of the synapses and their structural integrity were unchanged by the antibodies. This would indicate that the cadherins are used very specifically by the nerves for changing the strength of synapses, but not for the basic transmission of nerve impulses.

Finally, the inhibitory peptides were indeed effective in shutting down long-term potentiation, but only if they were introduced at the beginning of long-term potentiation. When the peptides were introduced about 30 minutes afterward, they had no effect.

This suggests that there may be factors other than the cadherins involved in long-term potentiation, and that these factors cannot be blocked by the peptides, Schuman explains. Like the antibodies, the peptides have no effect on baseline signal transmission or structural integrity when they disrupt the cadherins.

Also, it is known that calcium transiently leaves the synaptic junction during nerve impulses. And further, cadherins require calcium in order to stick together. Therefore, a possibility to explain the selective effect of the peptides on long-term potentiation initiation is that calcium leaving the junction during synaptic activity transiently destabilizes the cadherin bonds, thus allowing the blocking action of the peptides.

Schuman and colleagues find that elevating the concentration of calcium in the extracellular solution protects the cadherins from the inhibitory peptides. This suggests that cadherins might be able to work as "activity sensors" outside nerve cells by monitoring changes in calcium and then changing their binding to one another.

Taken together, the new results suggest that the cadherins are important in changing synapses in ways thought to be important to learning and memory. In addition to Schuman and Tang, the authors of the paper also include Chou P. Hung, who graduated from Caltech in 1996.

The research was supported by the Howard Hughes Medical Institute.

Writer: 
Robert Tindol
Writer: 

Parent that takes care of offspring tends to outlive the other parent, study shows

PASADENA--The parent who stays home to take care of the kids may be getting a good deal healthwise. New primate research from the California Institute of Technology shows that a primary caregiver tends to live longer than the other parent.

In a statistical study of 10 primate species, including humans, apes, and various Old and New World monkeys, the Caltech researchers show that the parent that cares for the offspring is significantly longer lived than the mate, regardless of gender. Titi monkey males of South America, for example, which take care of the baby after the mother has given birth, outlive their mates by 20 percent.

"The numbers show that if there is a difference in role, the sex doing the bulk of the care is likely to survive longer," says John Allman, a Caltech biology professor who is lead author of the study.

"This follows from the fact that it takes a lot of energy to raise a big-brained offspring like a human or an ape or a monkey," he adds. "The sex not caring for the infants will not be as crucial for the survival of the species."

The size of the brain is the key, Allman says. Species with big brains mature slowly and have only one baby at time, and these babies depend on their parents for a long time.

"Big brains are very expensive," Allman says. "They are costly in terms of time, energy and anatomical complexity. This reduces the reproductive potential of the parents because extra-special care must be provided to insure that this reduced number survive to reproductive age."

In an article appearing in the current issue of the journal Proceedings of the National Academy of Science, Allman and his coauthors outline their data from the 10 species of primates. To determine the lifespans of males and females that have borne offspring, the researchers analyzed the data from zoo populations, field studies, laboratory research, and human historical and demographic documents.

The researchers were especially interested in reviewing field studies as well as zoo data to ensure that artificial effects were not skewing the data. However there is also data from natural populations of primates that supports this hypothesis.

"Female gorillas, orangutans, and chimpanzees have a proportionally larger survival advantage than human females," Allman says. But the advantage of female gorillas is not so pronounced, and this could very well have to do with the fact that male gorillas play with their offspring and take on certain other nurturing duties.

In fact, the Caltech hypothesis is not only that the caregiver who takes care of the offspring tends to outlive his/her mate, but also that the effect disappears when parents share in caregiving more or less equally.

Perhaps for this reason human males and females also have lifespans that are fairly similar in length. The current figure is about 8 percent, but does not take into consideration the fact that medical care has significantly reduced the death rate from childbirth. Swedish demographic data from the late 1700s, by contrast, shows that females lived about 5 percent longer than their mates in those days, when childbirth was a leading cause of death in women.

The demographic data of the 10 primate species shows remarkable conformity to the hypothesis. In all of the primates studied in which females are the primary caregivers-spider monkeys, gibbons, orangutans and gorillas-females live significantly longer than males. Human female live longer than males, but the difference is smaller than in these primates and the male role is larger although less than the female role in childrearing.

In the two primates studied in which females and males share caregiving more or less equally, there is no difference between the survival rates of the sexes. In the two primate studies in which males have a larger role in caring for offspring, the owl monkey and the titi monkey, males live longer than females. The effect is significant for the owl monkeys, but not for titi monkeys because of the smaller sample available for these animals.

Allman acknowledges that the results are somewhat counterintuitive: many people think that child raising is quite stressful, and if anything should shorten the life of a harried parent. But just the opposite is true.

"There's probably not one single reason that the caregiver outlives the other parent," he says. "Risk taking in males and estrogen in females are probably factors, and there may even be a beneficial hormonal or chemical change that occurs through extending care to another.

"There's evidence that greater longevity can also coincide with the taking care of an elderly parent or even a pet," he concludes.

"So it could be that taking care of others is just good for you."

The other authors of the paper are Andrea Hasenstaub, a junior majoring in mathematics and engineering at Caltech; Aaron Rosin, a former Caltech student who graduated with a degree in biology; and Roshan Kumar, another Caltech graduate, who is now a researcher at the Scripps Research Institute in La Jolla, California.

Writer: 
Robert Tindol
Writer: 

Biologists discover fundamental genetic principle governing blood vessel formation

PASADENA--An unsuspected but fundamental genetic rule governing the formation of the cardiovascular system has been uncovered by biologists at the California Institute of Technology. The discovery could influence the development of therapies for both cardiovascular disease and cancer.

According to Caltech biology professor and Howard Hughes Medical Institute Investigator David Anderson, the new findings arrive amid an explosion of new information about the molecular basis of blood vesveins "have to 'talk' to each other to develop properly," says Anderson. The findings may help explain how an intact circulatory system, with the correct proportion of arteries and veins, can be put into place before the heart even begins to beat. The research appears in the current issue of the journal Cell.

By "talking," Anderson is referring to the major finding of the study, which is that complementary molecules found on surfaces of primitive arteries and veins must interact with each other for proper blood vessel formation to occur.

The findings may have broad implications, Anderson suggests. "One should reconsider the molecular biology, pathology, and drug therapies of the vascular system in terms of the molecular differences between arteries and veins." It is likely, says Anderson, that arteries and veins will differ in their expression of many other genes that have yet to be discovered. Such genes may lead to the development of new artery- or vein-specific drugs, or may help to target known drugs specifically to either arteries or veins. Such advances could potentially enhance the efficacy or specificity of blood vessel-directed anticancer drugs such as those discovered by Dr. Folkman. They could also aid in the treatment of diseases that selectively affect either arteries or veins.

Specifically, the Anderson team found that a molecule known as ephrin-B2, present on developing arteries, must communicate with its receptor Eph-B4, present on developing veins. These proteins are expressed by endothelial cells, the first cells that form primitive vessel-like tubules in the embryo and that go on to form the inner lining of arteries or veins. This process appears to be a fundamental interaction for the development of the embryo. If it fails to occur, embryonic development is blocked almost as soon as the heart begins to beat.

The discovery actually occurred when Anderson's graduate student, Hai Wang, was performing a gene knockout experiment to see if the ephrin-B2 gene is essential for the development of the nervous system. When Wang eliminated the gene that codes for ephrin-B2 in mouse embryos, he found no nervous system defects, but did notice that there were defects in the forming vascular system and heart.

The procedure involved the substitution of a "marker" gene that makes cells turn blue where the ephrin-B2 gene would normally be turned on. The result revealed, surprisingly, that the ephrin-B2 gene was expressed in arteries but not veins. Wang then showed that the receptor for ephrin-B2, Eph-B4, was expressed on veins but not arteries. Eph-B4 and ephrin-B2 fit together in a lock-and-key-like manner, signaling each cell that the other has been engaged. This complementarity was seen on vessels throughout the developing embryo. The fact that elimination of the ephrin-B2 gene caused defects in both arteries and veins suggests that not only do arteries send a signal to veins via ephrin-B2, but that veins must also signal back to arteries. The fact that both ephrin-B2 and Eph-B4 span the cell membrane suggests that each protein may be involved in both sending and receiving a signal.

Writer: 
Robert Tindol
Writer: 

Caltech Announces $100 million Drive For Biological Sciences

PASADENA—The California Institute of Technology has formally announced the goal of raising $100 million in a campaign to support new initiatives in the biological sciences.

The Biological Sciences Initiative (BSI) will allow the Institute to create approximately a dozen new faculty positions in biology and related disciplines, construct a new biology building on campus, develop new joint training programs with medical schools, and target several major biological questions that can be answered only through sustained research in state-of-the-art facilities.

"We intend to keep Caltech at the forefront of research in the biological sciences," says Camilla Frost, cochair of the BSI and member of the Caltech Board of Trustees.

According to Caltech president David Baltimore, a Nobel Prize–winning biologist, the campaign is designed to strengthen Caltech's ability to advance scientific knowledge and pave the way for new technologies.

"The 21st century will be the Golden Age of biology. We will see advances in both fundamental understanding of nature and medical technology for the treatment of disease.

"Our campaign is ultimately aimed at complex questions like the nature of consciousness, how memory and learning operate at the molecular level, how cells grow and die, and how genetic networks function," Baltimore says. "To answer these questions, we need the modern resources that only a major fundraising effort can provide for Caltech."

According to Ben Rosen, the other cochair of the BSI, approximately one-third of the $100 million has already been raised.

Caltech has a long history of biological innovation. For example, Thomas Hunt Morgan, Caltech's first biology chair, early in the century demonstrated that genes are linked in a series on chromosomes and are responsible for determining hereditary traits. A few decades later, Max Delbrück began studying bacteriophages (a class of viruses that infect bacteria), and in doing so became one of the first to apply the quantitative methods of physics to the study of genes.

More recently, Caltech's Ed Lewis won the 1995 Nobel Prize, for studying how genetic mutations affect early development.

The BSI's scientific program therefore furthers the investments Caltech has made in the biological sciences since the 1920s. According to Mel Simon, chair of the Division of Biology at Caltech, the campaign will provide significant impetus for "understanding the basic principles that underlie the behavior of genetically driven systems."

"If you ask what the world will look like in the year 2050, the answer is probably that we will have mastered how complex biological systems work," says Simon. "And we will be able to repair dysfunction in our own bodies and minds and use synthetic genetic approaches to maintain a natural and sustaining environment."

Rather than singling out specific scientific goals, Simon says that the BSI is aimed at further extending the remarkable advances that have been made in the past in biology in understanding how the brain works and how human beings develop.

"This is the next step in the evolution of biology at Caltech," he says. "The BSI will enable us to go beyond descriptions of genes and genetic networks to an understanding of how they function. We will go beyond the traditional disciplines and integrate our approaches with those of our colleagues in chemistry, physics, and engineering to achieve a more intimate understanding of how biology works.

"We see a broad range of possibilities that will clearly lead to new breakthroughs and new technology."

Writer: 
Robert Tindol

Neuroscientists locate area of brain responsible for 3-D vision

PASADENA--Researchers have found the brain circuitry that allows us to see the world in three dimensions even when one eye is closed.

In the current issue of the journal Nature, a team of neuroscientists at the California Institute of Technology reports that the middle temporal area (MT) of the brain renders certain visual motion cues into 3-D perceptions. Area MT is a small cortical area in each cerebral hemisphere located approximately an inch or two above the ears in both humans and non-human primates.

"We see the world in three dimensions even though the image in our retina is flat and in two dimensions," says Richard Andersen, who is the James G. Boswell Professor of Neuroscience at Caltech and principal investigator of the study, which was also conducted with postdoctoral fellow David Bradley and graduate student Grace Chang.

"So to derive the third dimension of depth, our nervous system has to process certain visual motion cues."

Andersen says that many people may assume that 3-D vision is explained solely by our having two eyes that provide a stereoscopic view of the world. But stereoscopic vision is fairly new in evolution, he says, while the depth-from-motion process is much more fundamental and primitive.

"In certain contrived situations, you can actually be better off by closing one eye," he says. For example, in a video animation his team created for the research project, an image of a cylinder is constructed entirely with points of light on a black field. When the cylinder is frozen, the viewer normally sees only a rectangular flat plane of light dots. But when the image is rotated, the viewer perceives a three-dimensional object.

"In this case, your stereoscopic vision may tell you the image is flat," he explains. "But area MT still overrides what you see with two eyes and gives you depth."

What's actually happening in the brain at such a time is a processing of the motions the eye perceives on the screen. While the spinning cylinder appears to have three dimensions, it actually comprises a series of dots that move horizontally across the screen at varying speeds. The dots near the edge of the cylinder image move more slowly across the screen, while the dots at the center move more quickly.

The brain picks up these varying speeds as natural motions in the world. The right and left edges of a cylinder naturally seem to move more slowly than the portion of the cylinder directly in front because the edges are moving forward and backward in that reference frame. And while there are no stereoscopic views in this display, the brain can still reconstruct the perception of depth using only the motions of the dots.

An especially important aspect of the study is the fact that viewers have a bias as to which direction they perceive the image to rotate, which changes spontaneously every few seconds. Because the cylinder is merely a group of dots moving at varying speeds, the image can appear to be rotating either clockwise or counterclockwise (see QuickTime movies below). Both human viewers and rhesus monkeys tend to perceive the cylinder as moving left to right (or counterclockwise), and then with time see it reverse.

"The beauty of this illusion is that the stimulus is always the same, but at different instances in time the perception is completely different," Andersen says.

"If the MT neurons were only coding the direction of motion of the dots in two dimensions, the cells would not change, since the physical stimulus never actually changes," he adds.

"So what we're actually watching is brain activity changing when an interpretation of the three-dimensional world changes," Andersen says.

Andersen says the research is aimed primarily at a fundamental scientific understanding of the biology of perception. However, the research could also eventually impact the treatment of human patients with vision deficits. In the very far future, the research could also perhaps be exploited for a technology leading to artificial vision.

 

smaller QuickTime movie (2.3MB)

 

larger QuickTime movie (5.9MB)

Writer: 
Robert Tindol

Caltech Biologists Pin Down Chain of Reactions That Turn On the Duplication of DNA

PASADENA—Caltech biologists have pinpointed the sequence of reactions that triggers the duplication of DNA in cells.

In companion papers appearing in recent issues of the journals Science and Cell, Assistant Professor of Biology Raymond Deshaies and his colleagues describe the chain of events that lead to the copying of chromosomes in a baker's yeast cell. Baker's yeast is often used as a model for human cells, so the research could have future implications for technology aimed at controlling cell reproduction, such as cancer treatments.

"We've provided a bird's-eye view of how a cell switches on the machinery that copies DNA," says Deshaies. "These principles can now be translated into a better understanding of how human cells proliferate."

The group's research keys primarily on how cells copy and segregate their chromosomes during the process of duplicating one cell into two. The new papers are concerned with how cells enter the DNA synthesis phase, during which the chromosomes are copied.

A question that cell biologists have sought for years to answer is that of which precise chemical events set off these reactions. The cell cycle is fundamental to the growth and division of all cells, but the process is somehow ramped down once the organism reaches maturity.

The paper appearing in Science describes how DNA synthesis is turned on. In the preceding stage (known as G1), proteins named G1 cyclins trigger the destruction of an inhibitor that keeps DNA synthesis from beginning.

This inhibitor sequesters an enzyme referred to as S-CDK (for DNA synthesis-promoting cyclin-dependent kinase), thereby blocking its action. Once the S-CDK is released, it switches on DNA synthesis. The S-CDK is present before the copying of DNA begins, but the DNA copying is not turned on until the S-CDK is freed of its inhibitor. The Deshaies group has shown that several phosphates are attached to the S-CDK inhibitor. These phosphates act as a molecular Velcro, sticking the inhibitor to yet another set of proteins called SCF.

The Cell paper essentially picks up on the description of the cell cycle at this point. The SCF, which acts like a molecular "hit man," promotes the attachment of another protein, ubiquitin. Ubiquitin in turn attracts the cellular garbage pail, proteasome. The inhibitor is disposed of in the proteasome, thereby freeing the S-CDK, which goes on to stimulate DNA duplication.

The process described above is quite complicated even in this condensed form, and actually is considerably more complicated in its technical details. But the detailed description that Deshaies and his colleagues have achieved is important fundamental science that could have technological implications in the future, Deshaies says.

"This traces the ignition of DNA synthesis down to a relatively small set of proteins," he says. "Any time you figure out how a part of the cell division machinery works, you can start thinking about devising new strategies to turn it on and off."

It is a precise turning on and off of DNA replication, many researchers think, that will someday be the key to better and more specific cancer-fighting drugs. Because a tumor is a group of cells that literally never stops the cell duplication cycle, a greater understanding of the cycle itself is almost certain to be a factor in further medical advances in cancer treatment.

"It could be five to 10 years, but this work could point the way to new cancer-fighting drugs," Deshaies says. "It is much easier to begin a rational approach to developing new treatments for cancer if you are armed with fundamental insights into how the cellular machinery works."

The other authors on the paper in the October 17 issue of Cell are R. M. Renny Feldman, a Caltech graduate student in biology; Craig C. Correll, a Caltech postdoctoral scholar in biology; and Kenneth B. Kaplan, a postdoctoral researcher at MIT.

The other authors of the Science paper from the October 17 issue are Rati Verma, a senior research fellow at Caltech; Gregory Reynard, a Caltech technician; and R. S. Annan, M. J. Huddleston, and S. A. Carr, all of the Research Mass Spectrometry Laboratory at SmithKline Beecham Pharmaceuticals in King of Prussia, Pennsylvania.

Writer: 
Robert Tindol
Writer: 

Caltech Scientists Devise First Neurochip

NEW ORLEANS—Caltech researchers have invented a "neurochip" that connects a network of living brain cells wired together to electrodes incorporated into a silicon chip.

The neurochips are being unveiled today at the annual meeting of the Society for Neurobiology, which is being held in New Orleans the week of October 25-30. According to Dr. Jerome Pine, one of the five coinventors of the neurochip, the technology is a major step forward for studying the development of neural networks.

The neurons used in the network are harvested from the hippocampus of rat embryos. Once the cells have been separated out by a protein-eating enzyme, each is individually inserted into a well in the silicon chip that is about half the diameter of a human hair. The cell is spherical in shape when it is inserted and is slightly smaller in diameter than the silicon chip well. When it is set in place and fed nutrients, it grows dendrites and an axon that spread out of the well.

In doing so, each neuron remains close to a single recording and stimulating electrode within the well, and also links up with other dendrites and axons attached to other neurons in other nearby wells.

According to Michael Maher, one of the coinventors, the neurochip currently has room for 16 neurons, which appear to develop normal connections with each other. "When the axons meet dendrites, they make an electrical connection," says Maher, who left Caltech in September to assume a postdoctoral appointment at UC San Diego. "So when one neuron fires, information is transmitted to the next neuron."

The neurochip network will be useful in studying the ways in which neurons maintain and change the strengths of their connections, Maher adds. "It's believed that memory in the brain is stored in the strength of these connections.

"This is pretty much a small brain connected to a computer, so it will be useful in finding out how a neural network develops and what its properties are. It will also be useful for studying chemical reactions at the synapses for weeks at a time. With conventional technology, you can record directly from at most a few neurons for at most a couple of hours."

There are two challenges facing the researchers as they attempt to improve the neurochips. One is providing the set of growth factors and nutrients to keep the cells alive for long periods of time. At present, two weeks is the limit.

The second challenge is finding a way to insert the cells in the silicon wells in a less time-consuming way. At present, the technique is quite labor intensive and requires a highly skilled technician with considerable patience and dexterity.

Other than the sheer effort involved, however, there is no reason that millions of cells could not be linked together at present, Maher says.

The other Caltech coinventors of the neurochip are Hanna Dvorak-Carbone, a graduate student in biology; Yu-Chong Tai, an associate professor of electrical engineering; and Tai's student, John Wright. The latter two are responsible for the silicon fabrication.

Writer: 
Robert Tindol
Writer: 

First Fully Automatic Design of a Protein Achieved by Caltech Scientists

PASADENA—Caltech scientists have found the Holy Grail of protein design. In fact, they've snatched it out of a giant pile of 1.9 x 1027 other chalices.

In the October 3 issue of the journal Science, Stephen L. Mayo, an Assistant Professor of Biology and a Howard Hughes Medical Institute Assistant Investigator, and chemistry graduate student Bassil I. Dahiyat report on their success in constructing a protein of their choice from scratch.

Researchers for some time have been able to create proteins in the lab by stringing together amino acids, but this has been a very hit-and-miss process because of the vast number of ways that the 20 amino acids found in nature can go together.

The number 1.9 x 1027, in fact, is the number of slightly different chains that 28 amino acids can form. And because slight differences in the geometry of protein chains are responsible for biological functions, the total control of formation is necessary to create new biological materials of choice.

By using a Silicon Graphics supercomputer to sort through all possible combinations for a selected protein, Mayo and Dahiyat have identified the target protein's best possible amino acid sequence. Then they have managed to take this knowledge and create the protein in the lab with existing technical processes.

This is a first, says Mayo. "Our goal has been to design brand-new proteins that do what we want them to do. This new result is the first major step in that direction. "Moreover, it shows that a computer program is the way to go in creating biological materials."

The technique they use, automated protein design, combines experimental synthesis of molecules with supercomputer-powered computational chemistry.

Proteins are the molecular building blocks of all living organisms. Composed of various combinations of the 20 amino acids, protein molecules can each comprise just a few hundred atoms, or literally millions of atoms. Most proteins involved in life processes have at least 100 amino acids, Mayo says.

Mayo and Dahiyat, who have been working on this research for five years, have developed a system that automatically determines the string of amino acids that will fold to most nearly duplicate the 3-D shape of a target structure. The system calculates a sequence's 3-D shape and evaluates how closely this matches the 3-D structure of the target protein.

One problem the researchers face is the sheer number of combinations needed to design a protein of choice. The protein that is the subject of this week's Science paper is a fragment of a fairly inconspicuous molecule involved in gene expression, and as such has only 28 amino acids. Even this small number takes a prodigious amount of computational power. A more desirable protein might involve 100 amino acids, which could make the staggering number of 10130 possible amino acid sequences.

Because this number is larger than the number of atoms in the universe, the researchers have had to find clever computational strategies to circumvent the impossible task of grinding out all the calculations.

In this case, the fastest way to the answer is by working backward. Starting with all the amino acid sequences possible for the protein, the computer program finds arrangements of amino acids that are a bad fit to the target structure. By repeatedly searching for, and eliminating, poorly matching amino acid combinations, the system rapidly converges on the best possible sequence for the target.

Subsequently, the simulation can be used to find other sequences that are nearly as good a fit as the best one.

This process has been honed by designing sequences for several different proteins, synthesizing them in the laboratory, and testing their actual properties.

With their innovative strategy, Mayo and Dahiyat are now reproducing proteins that are very similar to the target molecules. (The accompanying illustration shows how closely the protein they have formulated matches the target protein.)

But the goal is not just to create the proteins that already exist in nature. The researchers can actually improve on nature in certain circumstances. By making subtle changes in the amino acid sequence of a protein, for example, they are able to make a molecule more stable in harsh chemicals or hot environments (proteins tend to change irreversibly with a bit of heat, as anyone who has cooked an egg can attest).

"Our technology can actually change the proteins so that they behave a lot better," said Dahiyat, who recently finished his Caltech doctorate in chemistry and will now head Xencor, a start-up company established to commercialize the technology. The ability to create new proteins, and to adapt existing proteins to different environments and functions, could have profound implications for a number of emerging fields in biotechnology.

And, of course, it could help further the understanding of living processes.

"Paraphrasing Richard Feynman, if you can build it, you can understand it," says Mayo. "We think we can soon achieve a better understanding of proteins by going into a little dark room and building them to do exactly what we want them to do."

Writer: 
Robert Tindol
Writer: 

Caltech biologist named Beckman Young Investigator

PASADENA--Dr. Raymond Deshaies, a biochemist at the California Institute of Technology, has been named the newest Beckman Young Investigator by the Arnold and Mabel Beckman Foundation of Irvine, Calif. Deshaies will receive $200,000 over the next two years for his work on the mechanisms of cell division control. Much of his work concerns a single-celled organism familiarly known as baker's yeast, which for a variety of technical reasons is an excellent medium for fundamental research.

Dr. Steven E. Koonin, vice president and provost at Caltech, said in endorsing the nomination of Deshaies for the grant that his work is already taking advantage of the recently-completed genome sequence for yeast.

 

"Work done in many laboratories over the past several years has demonstrated that there is a remarkable similarity in the regulation of cell division among all eukaryotes--from the humble yeast cell to the far more complicated and varied ensemble of cells that comprise a human," Koonin wrote. "Cell division plays a critical role in normal development, and aberrations in the control of cell division can cause cancer."

 

Deshaies has been an assistant professor of biology at Caltech since January 1994. He earned his doctorate in 1988 at UC Berkeley, and has held postdoctoral appointments at both Berkeley and UC San Francisco.

 

The Arnold and Mabel Beckman Foundation, located in Irvine, Calif., makes grants to nonprofit research institutions to promote research in chemistry and the life sciences. Also, the grants are intended to foster the invention of methods, instruments and materials that will open up new avenues of research in science.

 

The Beckman Young Investigators program is intended to provide research support to the most promising young faculty members in the early stages of academic careers in the chemical and life sciences.

Exclude from News Hub: 
Yes

Scientists Find "Good Intentions" in the Brain

PASADENA—Neurobiologists at the California Institute of Technology have succeeded in peeking into one of the many "black boxes" of the primate brain. A study appearing in the March 13 issue of the journal Nature describes an area of the brain where plans for actions are formed.

It has long been known that we gain information through our senses and then respond to our world with actions via body movements. Our brains are organized accordingly, with some sections processing incoming sensory signals such as sights and sounds, and other sections regulating motor outputs such as walking, talking, looking, and reaching. What has puzzled scientists, however, is where in the brain thought is put into action. Presumably there must be an area between the sensory incoming areas and the motor outputting areas that decides or determines what we will do next.

Richard Andersen, James G. Boswell Professor of Neuroscience at Caltech, along with Senior Research Fellow Larry Snyder and graduate student Aaron Batista, chose the posterior parietal cortex as the likely candidate to perform such decisions. This is a high-functioning cognitive area and is the endpoint of what scientists call the visual "where" pathway. Lesions to the parietal cortex of humans result in loss of the ability to appreciate spatial relationships and to navigate accurately.

As Michael Shadlen of the University of Washington says in theNature "News and Views" commentary on the latest findings, "Nowhere in the brain is the connection between body and mind so conspicuous as in the parietal lobes—damage to the parietal cortex disrupts awareness of one's body and the space that it inhabits."

It is here, Andersen postulates, that incoming sensory signals overlap with outgoing movement commands, and it is here where decisions and planning occur. Numerous investigations had assumed a sensory map of external space must exist within the parietal cortex, so that certain subsections would be responsible for certain spatial locations of objects such as "up and to the left" or "down and to the right." Previous results from Andersen's own lab however had led him to question whether absolute space was the driving feature of the posterior parietal map or whether, instead, the intended movement plan was the determining factor in organizing the area.

In a series of experiments designed so that the scientists could "listen in" on the brain cells of monkeys at work, the animals were taught to watch a signal light and, depending on its color, to either reach to or look at the target. When the signal was green they were to reach and when it was red they were only to look at the target. An important additional twist to the study was that the monkeys had to withhold their responses for over a second.

The scientists measured neural activity during this delay when the monkeys had planned the movement but not yet made it. What they found was that different cells within different regions of the posterior parietal cortex became active, depending not so much on where the objects were but rather on which movements were required to obtain them. It seems then that the same visual input activates different subareas depending on how the animal plans to respond.

According to Andersen, this result shows that the pathway through the visual cortex that tells us where things are, ends in a map of intention rather than a map of sensory space as had been previously thought. According to Shadlen these results are intriguing because they indicate that "for the brain, spatial location is not a mathematical abstraction or property of a (sensory) map, but involves the issue of how the body navigates its hand or gaze." Andersen feels the study is important because it demonstrates that "our thoughts are more directly tied to our actions than we had previously imagined, and the posterior parietal cortex appears to be organized more around our intentions than our sensations."

Writer: 
Robert Tindol
Writer: 

Pages

Subscribe to RSS - BBE